CN1742758A - Medicine for treating diaper rash and ezcema and preparing method - Google Patents
Medicine for treating diaper rash and ezcema and preparing method Download PDFInfo
- Publication number
- CN1742758A CN1742758A CN 200510036351 CN200510036351A CN1742758A CN 1742758 A CN1742758 A CN 1742758A CN 200510036351 CN200510036351 CN 200510036351 CN 200510036351 A CN200510036351 A CN 200510036351A CN 1742758 A CN1742758 A CN 1742758A
- Authority
- CN
- China
- Prior art keywords
- weight
- medicine
- eczema
- diaper rash
- medicated powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The composition of medicine for effectively curing urine eruption and eczema includes (by wt%) 5%-45% of pine pollen, 5%-45% of talcum powder, 5%-45% of typha pollen and 5-45% of lygodium spore. Besides, said invention also provides its preparation method and concrete steps.
Description
Technical field
The present invention relates to the preparation method of a kind of Chinese medicine composition and said composition, particularly a kind of preparation method for the treatment of Chinese medicine composition and this medicine of diaper rash and eczema.
Background technology
At present, infant anthma and eczema are one of baby's common diseases that sickness rate is very high in the world, and is especially higher at developing countries' sickness rate.China also is the higher area of infantile eczema sickness rate, and especially in the rural area, sickness rate is then higher.Its cause of disease is commonly considered as owing in time do not changed by the wetted diaper of defecation, and carbamide is produced ammonia by the bacterial decomposition in the feces in the urine, and chafe makes its inflammation.In addition, diaper does not rinse or for a long time with blanket or Polypropylence Sheet, is that baby buttocks is in humid tropical condition, and this also is another major reason that causes eczema.This disease the lighter skin rubefaction, the routed intestinal of pimple, herpes or secondary infection etc. appears in weight person.Show as and keep crying incessantly, influence the necessary enough sleeps of baby, thereby have influence on infantile health.
Summary of the invention
Technical problem to be solved by this invention is, a kind of easy to use, medicine that consumption is few, rapid-action is provided.
The present invention also provides a kind of method for preparing said medicine.
Technical problem to be solved by this invention is achieved by the following technical solution: a kind of medicine for the treatment of diaper rash and eczema, it is characterized in that, it comprises following crude drug: part by weight is 5%～45% Pollen Pini, part by weight is 5%～45% Pulvis Talci, part by weight is 5%～45% Pollen Typhae, and part by weight is 5%～45% Spora Lygodii.
The present invention also provides a kind of method for preparing said medicine,
Because it is Spora Lygodii has eliminating damp-heat, treating stranguria analgesic effect, respond well to diseases such as treatment diaper rash, eczema, herpes zoster; Pollen Typhae has the treating stranguria effect of blood stasis dispelling, also has antiinflammatory action, and is better to disease effects such as treatment liquid permeability eczema, dermatitis; Pulvis Talci has clearing away summer-heat, dries and hold back skin ulcer, inducing diuresis for treating stranguria syndrome effect, has mucocutaneous, the antibacterial action of protection, to treating various dermatitis and eczema children's body heat miliaria etc. very good effect is arranged; Pollen Pini has dampness astringing to arrest bleeding function, is used for impetigo, skin eczema, erosion, baby diaper dermatitis, and treatment neonate diaper dermatitis, infantile eczema, diaper dermatitis etc. are had better effects.Medicine of the present invention is to be made by a certain percentage by the above-mentioned raw materials medicine, and the comprehensively effect of each crude drug is rapid to treatment diaper rash and eczema onset, and easy to use.
The specific embodiment
Embodiment one
A kind of medicine for the treatment of diaper rash and eczema, it comprises that it comprises following crude drug: part by weight is 5% Pollen Pini, and part by weight is 20% Pulvis Talci, and part by weight is 45% Pollen Typhae, and part by weight is 30% Spora Lygodii.
Embodiment two
A kind of medicine for the treatment of diaper rash and eczema, it comprises that it comprises following crude drug: part by weight is 25% Pollen Pini, and part by weight is 25% Pulvis Talci, and part by weight is 25% Pollen Typhae, and part by weight is 25% Spora Lygodii.
Embodiment three
A kind of medicine for the treatment of diaper rash and eczema, it comprises that it comprises following crude drug: part by weight is 20% Pollen Pini, part by weight is 25% Pulvis Talci, part by weight is 22% Pollen Typhae, part by weight is 25% Spora Lygodii, part by weight is 1.5% Borneolum Syntheticum, and part by weight is 1.5% Herba Menthae, and part by weight is that 2.5% Calamina and part by weight are 2.5% dry Alumen.
The medicine of making through clinic trial proof aforementioned proportion all has better effects to treatment diaper rash and eczema.
A kind of manufacturing method for above mentioned medicine, it comprises the steps:
A) drying is with Pollen Pini, Pulvis Talci, Pollen Typhae and Spora Lygodii oven dry, control water content;
B) batching and mixing, in the described ratio batching of claim 1, mixing obtains medicated powder A with above-mentioned medical material;
C) pulverize, medicated powder A is pulverized through the drum-type superfine communication technique, obtain the medicated powder B of particle diameter less than 25 μ m;
D) sieve, medicated powder B is crossed 100 mesh sieves.
E) packing.
Because it is Spora Lygodii has eliminating damp-heat, treating stranguria analgesic effect, respond well to diseases such as treatment diaper rash, eczema, herpes zoster; Pollen Typhae has the treating stranguria effect of blood stasis dispelling, also has antiinflammatory action, and is better to disease effects such as treatment liquid permeability eczema, dermatitis; Pulvis Talci has clearing away summer-heat, dries and hold back skin ulcer, inducing diuresis for treating stranguria syndrome effect, has mucocutaneous, the antibacterial action of protection, to treating various dermatitis and eczema children's body heat miliaria etc. very good effect is arranged; Pollen Pini has dampness astringing to arrest bleeding function, is used for impetigo, skin eczema, erosion, baby diaper dermatitis, and treatment neonate diaper dermatitis, infantile eczema, diaper dermatitis etc. are had better effects.Medicine of the present invention is to be made by a certain percentage by the above-mentioned raw materials medicine, and the comprehensively effect of each crude drug is rapid to treatment diaper rash and eczema onset through the clinic trial proof, and easy to use.
The present invention also has some other distortion or improvement.Can be 0～3% as auxiliary raw material medicine Borneolum Syntheticum part by weight, the part by weight of Herba Menthae can be 0～3%, and the part by weight of Calamina can be 0～5%, and it is 0～5% that the part by weight of dry Alumen can be; In addition, this medicine adds the conventional adjuvant of pharmacy, can make any dosage form in unguentum, powder, spray, suppository and the liquid preparation; Pulverizing to medicated powder A also can be adopted the air-flowing type superfine communication technique; If those skilled in the art are subjected to the change or the improvement of the conspicuous unsubstantiality that inspiration of the present invention makes, all belong to the protection domain of claims of the present invention.
Claims (9)
1, a kind of medicine for the treatment of diaper rash and eczema is characterized in that, it comprises following crude drug:
Part by weight is 5%～45% Pollen Pini, and part by weight is 5%～45% Pulvis Talci, and part by weight is 5%～45% Pollen Typhae, and part by weight is 5%～45% Spora Lygodii.
2, the medicine of treatment diaper rash according to claim 1 and eczema is characterized in that, Pollen Pini, Pulvis Talci, Pollen Typhae and Spora Lygodii part by weight are 25% in the crude drug.
3, the medicine of treatment diaper rash according to claim 1 and eczema, it is characterized in that this medicine also comprises following crude drug: part by weight is 0～3% Borneolum Syntheticum, and part by weight is 0～3% Herba Menthae, part by weight is 0～5% Calamina, and part by weight is 0～5% dry Alumen.
4, the medicine of treatment diaper rash according to claim 1 and eczema is characterized in that, this medicine adds the conventional adjuvant of pharmacy, makes any dosage form in unguentum, powder, spray, suppository and the liquid preparation.
5, a kind of preparation method of medicine according to claim 1 is characterized in that, it comprises the steps:
A. dry, with Pollen Pini, Pulvis Talci, Pollen Typhae and Spora Lygodii oven dry, control water content;
B. batching and mixing are prepared burden above-mentioned medical material in the described ratio of claim 1, and mixing obtains medicated powder A;
C. pulverize, A pulverizes through superfine communication technique with medicated powder, obtains medicated powder B;
D. sieve, medicated powder B is crossed 100 mesh sieves.
6, process for preparing medicine according to claim 5 is characterized in that, also comprises the technical process that is packaged into finished product after sieving.
7, process for preparing medicine according to claim 5 is characterized in that, the particle diameter of the medicated powder B that obtains among the step c is less than 25 μ m.
8, process for preparing medicine according to claim 5 is characterized in that, the superfine communication technique among the step c is the drum-type superfine communication technique.
9, process for preparing medicine according to claim 5 is characterized in that, the superfine communication technique among the step c is the air-flowing type superfine communication technique.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510036351 CN1742758A (en) | 2005-08-05 | 2005-08-05 | Medicine for treating diaper rash and ezcema and preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510036351 CN1742758A (en) | 2005-08-05 | 2005-08-05 | Medicine for treating diaper rash and ezcema and preparing method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1742758A true CN1742758A (en) | 2006-03-08 |
Family
ID=36138383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510036351 Pending CN1742758A (en) | 2005-08-05 | 2005-08-05 | Medicine for treating diaper rash and ezcema and preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1742758A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101391000B (en) * | 2007-09-18 | 2013-05-01 | 丽珠集团利民制药厂 | External medicine composition for treating the eczema and preparation method thereof |
| CN105168274A (en) * | 2015-10-22 | 2015-12-23 | 俞祖勋 | Powder for preventing diaper rashes as well as preparation method and application method thereof |
-
2005
- 2005-08-05 CN CN 200510036351 patent/CN1742758A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101391000B (en) * | 2007-09-18 | 2013-05-01 | 丽珠集团利民制药厂 | External medicine composition for treating the eczema and preparation method thereof |
| CN105168274A (en) * | 2015-10-22 | 2015-12-23 | 俞祖勋 | Powder for preventing diaper rashes as well as preparation method and application method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103356990B (en) | Bedsore paste | |
| CN101554424B (en) | Traditional Chinese medicine for treating skin diseases and preparation method thereof | |
| CN103520381B (en) | Beriberi-removing foot-bath powder and preparation method thereof | |
| CN103599029B (en) | Anti-inflammation compositions, talcum powder and preparation method thereof | |
| CN1309400C (en) | Chinese medicinal composition for skin caring and its application method | |
| CN1742758A (en) | Medicine for treating diaper rash and ezcema and preparing method | |
| CN102716060B (en) | Pine needle powder-superfine microcrystalline cellulose toilet powder and manufacturing method thereof | |
| CN1319574C (en) | Medicine for treating constipation | |
| CN102755428B (en) | Calculus bovis yijin tablet for treating chronic pharyngitis and preparation method thereof | |
| CN104258316A (en) | Pharmaceutical composition for treating rheumatic arthritis and preparation method thereof | |
| CN1203887C (en) | Traditional Chinese medicine for treating arthralgia and preparation process thereof | |
| CN103656107A (en) | Medicine for treating tinea favosa and preparation method thereof | |
| CN104147416A (en) | Talcum powder for treating infant diaper rash and preparation method thereof | |
| CN105194263A (en) | Traditional Chinese medicine composition for treating rheumatic skin itching and preparation method thereof | |
| CN101537109B (en) | Medicine for treating throat diseases and preparation method thereof | |
| CN103610928B (en) | A kind of Chinese medicine for the treatment of anaphy lactoid purpura nephritis | |
| CN102727669B (en) | Compound propolis composition used for treating swine erysipelas, and preparation method thereof | |
| CN106310056A (en) | External medicine for treating beriberi | |
| CN104840822A (en) | Traditional Chinese medicine composition for treating otitis media | |
| CN104784666A (en) | Traditional Chinese medicine ointment for orthopedic nursing | |
| CN1057692C (en) | Chinese patent drug | |
| CN104758842A (en) | Traditional Chinese medicinal preparation for treating acute appendicitis | |
| CN103735650A (en) | Chinese herb preparation for treating infectious canine hepatitis | |
| CN1088801A (en) | Chinese patent medicine Jinguanpian tablets and the method for making thereof of treatment insensitive impediment, particularly RA and AS | |
| CN116019850A (en) | A Chinese medicinal powder for relieving pain, and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |